CS Diagnostics Corp.

10/31/2025 | Press release | Distributed by Public on 10/31/2025 09:48

CS Interpharm and CS Diagnostics Pharma Complete Conversion of Preferred Shares to Common Stock, Strengthening CSDX's Path to Consolidated Financial Reporting

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
CS Diagnostics Corp. published this content on October 31, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 31, 2025 at 15:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]